{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:55:30Z","timestamp":1791572130625,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.vaccine.2003.11.064","type":"journal-article","created":{"date-parts":[[2004,4,9]],"date-time":"2004-04-09T05:21:57Z","timestamp":1081488117000},"page":"2396-2405","source":"Crossref","is-referenced-by-count":74,"title":["Pluronic\u00ae F127-based systemic vaccine delivery systems"],"prefix":"10.1016","volume":"22","author":[{"given":"Claire M.","family":"Coeshott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.Louise","family":"Smithson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evie","family":"Verderber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Samaniego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan M.","family":"Blonder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary J.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.Julie","family":"Westerink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2003.11.064_BIB1","doi-asserted-by":"crossref","unstructured":"Gupta RK, Rost BE, Relyveld E, Siber GR. Adjuvant properties of aluminium and calcium compounds. In: Powell MF, Newman MJ, editors. Vaccine design, the subunit and adjuvant approach. New York: Plenum Press; 1995. p. 229\u201348.","DOI":"10.1007\/978-1-4615-1823-5_8"},{"key":"10.1016\/j.vaccine.2003.11.064_BIB2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0264-410X(01)00423-6","article-title":"Projuvant\u2122 (Pluronic F127\u00ae\/chitosan) enhances the immune reponse to intranasally administered tetanus toxoid","volume":"20","author":"Westerink","year":"2002","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2003.11.064_BIB3","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1021\/js970034d","article-title":"Drug delivery matrix containing native protein precipitates suspended in a poloxamer gel","volume":"86","author":"Stratton","year":"1997","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.vaccine.2003.11.064_BIB4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1139\/y97-003","article-title":"Acute and chronic response to vanadium following two methods of streptozotocin-diabetes induction","volume":"75","author":"Yao","year":"1997","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.vaccine.2003.11.064_BIB5","first-page":"183","article-title":"Enhanced stability of two model proteins in an agitated solution environment using poloxamer 407","volume":"47","author":"Wang","year":"1993","journal-title":"J. Parenter. Sci. Technol."},{"issue":"10","key":"10.1016\/j.vaccine.2003.11.064_BIB6","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1128\/IAI.68.10.5764-5770.2000","article-title":"Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens [In Process Citation]","volume":"68","author":"Bacon","year":"2000","journal-title":"Infect. Immun."},{"issue":"20","key":"10.1016\/j.vaccine.2003.11.064_BIB7","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0264-410X(98)00077-2","article-title":"Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice","volume":"16","author":"Jabbal-Gill","year":"1998","journal-title":"Vaccine"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2003.11.064_BIB8","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0264-410X(00)00309-1","article-title":"A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery","volume":"19","author":"McNeela","year":"2000","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2003.11.064_BIB9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0264-410X(00)00248-6","article-title":"Immune stimulating activity of two new chitosan containing adjuvant formulations","volume":"19","author":"Seferian","year":"2000","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2003.11.064_BIB10","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1128\/IAI.68.3.1450-1456.2000","article-title":"CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies","volume":"68","author":"Chu","year":"2000","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.vaccine.2003.11.064_BIB11","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4049\/jimmunol.160.2.870","article-title":"CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen","volume":"160","author":"Davis","year":"1998","journal-title":"J. Immunol."},{"issue":"2-3","key":"10.1016\/j.vaccine.2003.11.064_BIB12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0264-410X(00)00172-9","article-title":"CpG DNA as a Th1-promoting adjuvant in immunization against Trypanosoma cruzi","volume":"19","author":"Corral","year":"2000","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2003.11.064_BIB13","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1073\/pnas.94.20.10833","article-title":"Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization","volume":"94","author":"Weiner","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.vaccine.2003.11.064_BIB14","unstructured":"Shiigi SM, editor. Selected methods in cellular immunology, vol. xxix. Freeman; 1980. p. 486."},{"issue":"32","key":"10.1016\/j.vaccine.2003.11.064_BIB15","doi-asserted-by":"crossref","first-page":"19103","DOI":"10.1016\/S0021-9258(19)47273-6","article-title":"A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo","volume":"264","author":"Singh","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.vaccine.2003.11.064_BIB16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0022-1759(89)90397-9","article-title":"Re-examination and further development of a precise and rapid dye method for measuring cell growth\/cell kill","volume":"119","author":"Hansen","year":"1989","journal-title":"J. Immunol. Methods"},{"issue":"8","key":"10.1016\/j.vaccine.2003.11.064_BIB17","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0264-410X(96)00262-9","article-title":"Immunization of mice with DNA encoding fragment C of tetanus toxin","volume":"15","author":"Anderson","year":"1997","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2003.11.064_BIB18","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0952-7915(99)80029-6","article-title":"B cell memory and the long-lived plasma cell","volume":"11","author":"McHeyzer-Williams","year":"1999","journal-title":"Curr. Opin. Immunol."},{"issue":"3","key":"10.1016\/j.vaccine.2003.11.064_BIB19","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0952-7915(98)80162-3","article-title":"Long-lived plasma cells: a mechanism for maintaining persistent antibody production","volume":"10","author":"Slifka","year":"1998","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.vaccine.2003.11.064_BIB20","unstructured":"Basic and Clinical Immunology, Norwalk, Conn: Appleton & Lange; 1991."},{"issue":"3","key":"10.1016\/j.vaccine.2003.11.064_BIB21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1074-7613(00)80541-5","article-title":"Humoral immunity due to long-lived plasma cells","volume":"8","author":"Slifka","year":"1998","journal-title":"Immunity"},{"issue":"17","key":"10.1016\/j.vaccine.2003.11.064_BIB22","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0264-410X(99)00526-5","article-title":"CpG DNA induces stronger immune responses with less toxicity than other adjuvants","volume":"18","author":"Weeratna","year":"2000","journal-title":"Vaccine"},{"issue":"45","key":"10.1016\/j.vaccine.2003.11.064_BIB23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0264-410X(00)00208-5","article-title":"Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants","volume":"19","author":"McCluskie","year":"2000","journal-title":"Vaccine"},{"issue":"1719","key":"10.1016\/j.vaccine.2003.11.064_BIB24","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1016\/S0264-410X(00)00496-5","article-title":"The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants","volume":"19","author":"McCluskie","year":"2001","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2003.11.064_BIB25","first-page":"35","article-title":"The use of CpG DNA as a mucosal vaccine adjuvant","volume":"2","author":"McCluskie","year":"2001","journal-title":"Curr. Opin. Investig. Drugs"},{"issue":"5","key":"10.1016\/j.vaccine.2003.11.064_BIB26","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.4049\/jimmunol.161.5.2428","article-title":"CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge","volume":"161","author":"Krieg","year":"1998","journal-title":"J. Immunol."},{"issue":"2324","key":"10.1016\/j.vaccine.2003.11.064_BIB27","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1016\/S0264-410X(99)00145-0","article-title":"Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys","volume":"17","author":"Jones","year":"1999","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2003.11.064_BIB28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0264-410X(02)00378-X","article-title":"CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein","volume":"21","author":"Ioannou","year":"2002","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2003.11.064_BIB29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0014-5793(92)80655-Z","article-title":"The polyoxyethylene\/polyoxypropylene block co-polymer poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow","volume":"305","author":"Porter","year":"1992","journal-title":"FEBS Lett."},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2003.11.064_BIB30","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/S0264-410X(98)00363-6","article-title":"Long-term protection of mice against Leishmania major with a synthetic peptide vaccine","volume":"17","author":"Spitzer","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.064_BIB31","unstructured":"Reed C. PhD thesis. University of Strathclyde; 1993."},{"issue":"11","key":"10.1016\/j.vaccine.2003.11.064_BIB32","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/sj.gt.3301189","article-title":"A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle","volume":"7","author":"Lemieux","year":"2000","journal-title":"Gene Ther."},{"issue":"Pt. 1","key":"10.1016\/j.vaccine.2003.11.064_BIB33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/BA20000022","article-title":"Improvement of receptor-mediated gene delivery to HepG2 cells using an amphiphilic gelling agent","volume":"32","author":"Cho","year":"2000","journal-title":"Biotechnol. Appl. Biochem."},{"issue":"5","key":"10.1016\/j.vaccine.2003.11.064_BIB34","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/sj.bmt.1703816","article-title":"Delivery of Flt3 ligand (Flt3L) using a poloxamer-based formulation increases biological activity in mice","volume":"31","author":"Robinson","year":"2003","journal-title":"Bone Marrow Transplant."},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2003.11.064_BIB35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0169-409X(00)00144-7","article-title":"Factors affecting short-term and long-term stabilities of proteins","volume":"46","author":"Arakawa","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.vaccine.2003.11.064_BIB36","unstructured":"Shan D, Beekman A, Hartley C, Cooke K, McElroy T, Zordich M, et al. A G-CSF sustained release formulation using a glycerol oil suspension: in vivo studies. In: 28th International Symposium on Controlled Release of Bioactive Materials, 2001."},{"key":"10.1016\/j.vaccine.2003.11.064_BIB37","doi-asserted-by":"crossref","unstructured":"Joellenbeck LM, Zwanziger LL, Durch JS, Strom BL, editors. The anthrax vaccine. Is it safe? Does it work? Washington, DC, USA: National Academy Press; 2002. p. 265.","DOI":"10.21236\/ADA403352"},{"key":"10.1016\/j.vaccine.2003.11.064_BIB38","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2105\/AJPH.52.4.632","article-title":"Field evaluation of a human anthrax vaccine","volume":"52","author":"Brachman","year":"1962","journal-title":"Am. J. Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2003.11.064_BIB39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1081\/CLT-100102885","article-title":"Delayed life-threatening reaction to anthrax vaccine","volume":"39","author":"Swanson-Biearman","year":"2001","journal-title":"J. Toxicol. Clin. Toxicol."},{"issue":"3","key":"10.1016\/j.vaccine.2003.11.064_BIB40","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1023\/A:1015815624334","article-title":"Sustained delivery of interleukin-2 from a poloxamer 407 gel matrix following intraperitoneal injection in mice","volume":"9","author":"Johnston","year":"1992","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/j.vaccine.2003.11.064_BIB41","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.2042-7158.1995.tb05829.x","article-title":"Percutaneous absorption of indomethacin from pluronic F127 gels in rats","volume":"47","author":"Miyazaki","year":"1995","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.vaccine.2003.11.064_BIB42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/10837459709022619","article-title":"Use of poloxamer polymers to stabilize recombinant human growth hormone against various processing stresses","volume":"2","author":"Katakam","year":"1997","journal-title":"Pharm. Dev. Technol."},{"issue":"10","key":"10.1016\/j.vaccine.2003.11.064_BIB43","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1021\/js980222j","article-title":"Evaluation of pluronic F127-based sustained-release ocular delivery systems for pilocarpine using the albino rabbit eye model","volume":"87","author":"Desai","year":"1998","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.vaccine.2003.11.064_BIB44","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1021\/js970090e","article-title":"In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpine","volume":"87","author":"Desai","year":"1998","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.vaccine.2003.11.064_BIB45","first-page":"1431","article-title":"In vivo characterization of sustained-release formulations of human growth hormone","volume":"281","author":"Lee","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"12","key":"10.1016\/j.vaccine.2003.11.064_BIB46","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1023\/A:1016264527738","article-title":"Controlled release of lidocaine from injectable gels and efficacy in rat sciatic nerve block","volume":"12","author":"Paavola","year":"1995","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.vaccine.2003.11.064_BIB47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0169-409X(98)00007-6","article-title":"Preface","volume":"32","author":"Newman","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.vaccine.2003.11.064_BIB48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-3083.1986.tb01970.x","article-title":"The adjuvant activity of nonionic block polymer surfactants. III. Characterization of selected biologically active surfaces","volume":"23","author":"Hunter","year":"1986","journal-title":"Scand. J. Immunol."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04002488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04002488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T03:11:56Z","timestamp":1682651516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04002488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":48,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0264410X04002488"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.11.064","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}